Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome

Background. Dyslipidemia is one of the most serious modifiable risk factors for acute coronary  syndrome which is the most leading cause of mortality and morbidity worldwide.Aim. To assess the short-term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ...

Full description

Bibliographic Details
Main Authors: Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
Format: Article
Language:English
Published: Столичная издательская компания 2018-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
atorvastatin
rosuvastatin
acute coronary syndrome
statins
Online Access:https://www.rpcardio.online/jour/article/view/1743

Similar Items

Similar Items